Study of Visual Mecanisms Involved in Face Recognition
Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Feb 24, 2025
Trial Information
Current as of November 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how our brains recognize faces by looking at the visual information we receive and how it combines with what we already know. Researchers want to understand the brain's processes better, especially how the visual system refines the way we see and understand faces. By using advanced imaging techniques, they will observe the brain's activity while participants look at different faces to learn more about how we recognize them in our daily lives.
To participate, you need to be between 18 and 50 years old, have normal eyesight or wear contact lenses, and not have any neurological disorders or metal implants in your body. The study is not yet recruiting participants, but if you qualify, you can expect to spend time in an MRI machine, which takes pictures of your brain while you look at faces. It's important to note that if you're claustrophobic or have any health issues listed in the eligibility criteria, you may not be able to participate. This research will help scientists gain insights into how we process important social information, like recognizing faces.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Participants will be screened (see annex 2) to ascertain they fit with all these inclusion criteria:
- • Be between 18 and 50 years old,
- • have normal eyesight or eyesight corrected with contact lenses,
- • Have no neurological disorder,
- • Not have had a skull fracture or head surgery,
- • Have no chronic progressive illness or mental deficiency,
- • Have no metal parts in their body (dental braces or pins, metal plates, pacemakers, implanted prostheses, etc.),
- • Have no tattoos containing metallic particles or implanted jewellery (e.g. piercings) that cannot be removed,
- • Not to have worked with metals,
- • Do not take any medicines or substances that may affect brain function (e.g. drugs, energy drinks, alcohol),
- • Not to be pregnant or breastfeeding.
- • Do not be claustrophobic.
- Exclusion Criteria:
- • Participants presenting a counter-indication (responding yes to one of the questions of the screening questionnaire, see annex 2) to participate will be excluded from participation.
- Participants will be screened to ascertain they do not present any of these counter-indications to the participation to the MRI measurement. We will exclude people with these characteristics:
- • Be younger than 18 or older than 50 years old,
- • have poor eyesight,
- • Have neurological disorder,
- • have had a skull fracture or head surgery,
- • Have a chronic progressive illness or mental deficiency,
- • Have metal parts in their body (dental braces or pins, metal plates, pacemakers, implanted prostheses, etc.),
- • Have tattoos containing metallic particles or implanted jewellery (e.g. piercings) that cannot be removed,
- • have worked with metals,
- • take medicines or substances that may affect brain function (e.g. drugs, energy drinks, alcohol),
- • pregnant or breastfeeding.
- • claustrophobic.
About Université Catholique De Louvain
Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Valerie Goffaux, PhD
Study Director
Université Catholique de Louvain
Mrittika Dey, Master
Principal Investigator
Université Catholique de Louvain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported